PDSS2
protein-codingdecaprenyl diphosphate synthase subunit 2
Gene summary
The protein encoded by this gene is an enzyme that synthesizes the prenyl side-chain of coenzyme Q, or ubiquinone, one of the key elements in the respiratory chain. The gene product catalyzes the formation of all trans-polyprenyl pyrophosphates from isopentyl diphosphate in the assembly of polyisoprenoid side chains, the first step in coenzyme Q biosynthesis. Defects in this gene are a cause of coenzyme Q10 deficiency.[provided by RefSeq, Oct 2009]
- C6orf210
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~307.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013838
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013838
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013838
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between PDSS2 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of July 13, 2020. The PDSS2 gene encodes prenyl diphosphate synthase subunit 2, which is important early in the coenzyme Q10 biosynthesis pathway. Coenzyme Q10 is critical for many processes in the cell, including in the mitochondrial respiratory chain transferring electrons from complexes I and II to complex III. The PDSS2 gene was first reported in association with autosomal recessive Leigh syndrome spectrum in 2006 (PMID: 17186472). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included two variants identified in one cases from one publications (PMID: 17186472), as well as a case reported in a book chapter (Quinzii C, Loos M. Multisystemic Infantile CoQ10 Deficiency with Renal Involvement. In: Russell P. Saneto, Sumit Parikh and Bruce H. Cohen, editors. Mitochondrial Case Studies Underlying Mechanisms and Diagnosis. Academic Press; 2016. pp 299-04). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, expression, functional alteration in patient cells, functional alteration in non-patient cells, and animal models (PMIDs: 27977873, 21139605, 17186472, 29967258, 18437205, 23150520). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on July 13, 2020 (SOP Version 7).
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic; Renal
Intervention: Biochemical
Rationale: Treatment with Coenzyme Q10 supplementation may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PDSS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020381.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 70 | 72 | |||
| missense | 3 | 117 | 8 | 2 | 130 | |
| nonsense | 1 | 4 | 5 | |||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 3 | 6 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 3 | 5 | ||
| Total | 1 | 8 | 130 | 78 | 2 | 219 |
Highest pathogenic variant AF is 0.000076221404
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_065114.3 | 8 | MANE Select | |
| Ensembl | ENSP00000358033.4 | 8 | MANE Select | |
| Ensembl | ENSP00000358027.4 | 4 | Standard | |
| Ensembl | ENSP00000358027.4 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Terpenoid backbone biosynthesis - Homo sapiens (human)
- Metabolism
- Ubiquinol biosynthesis
- Metabolism of cofactors
- Metabolism of vitamins and cofactors
Biological Process
- ubiquinone biosynthetic process
- isoprenoid biosynthetic process
- regulation of body fluid levels
- protein heterotetramerization
Molecular Function
- trans-hexaprenyltranstransferase activity
- protein heterodimerization activity
- trans-octaprenyltranstransferase activity
Cellular Component
- mitochondrial matrix
- cytosol
- transferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369037
- Coding exons
- 8
- Length
- 307008
- Individuals with no LoFs
- 125709
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 39
- Defined
- 125748
- p
- 0.000155
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.474 | 196 | 216 | 0.909 | 0.0000100 | 2603 |
| Missense (PolyPhen) | 50 | 72.473 | 0.68992 | 871 | ||
| Synonymous | 0.813 | 74 | 83.4 | 0.887 | 0.00000400 | 789 |
| Loss of Function | 1.12 | 14 | 19.3 | 0.724 | 8.59e-7 | 234 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.0015 | 0.0015 | notable |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00012 | 0.00012 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Supplies decaprenyl diphosphate, the precursor for the side chain of the isoprenoid quinones ubiquinone-10. {ECO:0000269|PubMed:16262699}.;
- Disease
- DISEASE: Coenzyme Q10 deficiency, primary, 3 (COQ10D3) [MIM:614652]: A fatal encephalomyopathic form of coenzyme Q10 deficiency with nephrotic syndrome. Coenzyme Q10 deficiency is an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form. {ECO:0000269|PubMed:17186472}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- LoFtool
- 0.742
- RVIS EVS
- -0.07
- RVIS percentile EVS
- 48.54
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.0635
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |